Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 20, 2021
High-income countries play a key role in the global response to Omicron. Their decisions can help increase global vaccination coverage, curb the spread of current variants, and prevent the emergence of new ones. Here we outline three actions high-income countries should take to help end the pandemic...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Blog Post
November 29, 2021
While hopes for mobilizing private finance for climate response were boosted by the investment firms managing a collective $130 trillion who signed onto net zero pledges at the COP, actually getting the private trillions to move south remains a huge challenge. And two leading proposals point to the ...
Blog Post
November 18, 2021
In a new report, we rely on public reporting from multilateral development institutions and funds to provide a clearer picture of China’s participation across the multilateral development system. We find that China has staked out a uniquely important position, one that relies on leading roles as a s...
Blog Post
October 25, 2021
At a glance, it would seem that if you want to tackle climate finance, you ought to look to institutions with “climate” in the name. Yet, whatever the longer-term potential of the Green Climate Fund (GCF), the reality is that it has committed just $10 billion and disbursed a meager $1.7 billion in c...
Blog Post
October 21, 2021
After buying up the World’s vaccine supply to ensure they can protect their own populations, rich countries have found themselves struggling to use the vaccine surpluses they accumulated. One response has been to donate the spare doses to countries who need them more. This is laudable, and countries...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...